Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The artemisinin derivatives are now used widely in areas with multidrug-resistant Plasmodium falciparum malaria such as Southeast Asia, but concerns remain over their potential for neurotoxicity. Mice, rats, dogs, and monkeys treated with high doses of intramuscular artemether or arteether develop an unusual pattern of focal damage to brain stem nuclei (particularly those involved in auditory processing). To investigate whether a similar toxic effect occurs in patients treated with these compounds, clinical neurologic evaluation, audiometry and early latency auditory evoked responses were measured in a single-blind comparison of 79 patients who had been treated with > or =2 courses of oral artemether or artesunate within the previous 3 years, and 79 age- and sex-matched controls living in a malaria-endemic area on the northwestern border of Thailand. There were no consistent differences in any of these test results between the cases and controls. This study failed to detect any evidence of significant neurotoxicity in patients treated previously with oral artemether or artesunate for acute malaria.

Original publication




Journal article


Am J Trop Med Hyg

Publication Date





65 - 69


Adolescent, Adult, Animals, Antimalarials, Artemether, Artemisinins, Artesunate, Audiometry, Case-Control Studies, Child, Child, Preschool, Drug Resistance, Multiple, Drug Therapy, Combination, Evoked Potentials, Auditory, Brain Stem, Female, Follow-Up Studies, Humans, Malaria, Falciparum, Male, Mefloquine, Middle Aged, Plasmodium falciparum, Sesquiterpenes, Thailand